Efficient traffic sign recognition using YOLO for intelligent transport systems

C Cong Wang (Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066) B Bin Zheng (Academy of Medical Engineering and Translational Medicine, Department of Medicine) C Chenxing Li (School of Chemistry)

Abstract

Abstract Accurate traffic sign recognition (TSR) is critical for enhancing the safety and reliability of autonomous driving systems. This study proposes an optimized YOLOv5-based framework to address challenges such as small-scale detection, environmental variability, and real-time processing constraints. Three key innovations are introduced: (1) k-means++ clustering for anchor box optimization, achieving a 77.55% average IoU (vs. 75.95% for traditional k-means) to enhance small-target detection; (2) comprehensive comparative analysis of YOLOv5 variants (s/m/x), revealing precision-speed trade-offs (99.3–99.5% mAP@0.5 vs. 32–45 ms inference time) for deployment flexibility; and (3) systematic hyperparameter tuning to maximize robustness across diverse scenarios. Leveraging the CCTSDB dataset (13,830 annotated images), experiments demonstrate the framework’s superiority: it attains 98.1% mean average precision (mAP), 98.6% recall, and 99.3% precision, outperforming Faster-RCNN and SSD by 5–8% in mAP while maintaining 45 FPS throughput. The YOLOv5s variant achieves optimal balance with 99.3% mAP@0.5 and 32 ms per-image inference, validated through rigorous statistical analysis (Tukey HSD). Robust performance in challenging conditions (e.g., small sample, backlit sample, foggy scenes) is evidenced by detection confidence exceeding 0.90. These results highlight the framework’s applicability in latency-sensitive intelligent transportation systems.

Article Details

Volume / Issue Vol. 15, Issue 1
Published April 21, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (3)

C

Cong Wang

Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066

B

Bin Zheng

Academy of Medical Engineering and Translational Medicine, Department of Medicine

C

Chenxing Li

School of Chemistry